Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Stanford University
Stanford University
Swiss Cancer Institute
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology